Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -94,318 | -79,992 | -324,289 | -211,561 | -108,330 |
| Depreciation Amortization | 2,877 | 6,336 | 3,926 | 2,599 | 1,679 |
| Accounts payable and accrued liabilities | 2,216 | 6,040 | 4,846 | 6,435 | 3,793 |
| Other Working Capital | -55,586 | -121,328 | -21,936 | -20,142 | -26,023 |
| Other Operating Activity | 16,298 | -156,158 | 75,640 | 42,335 | 24,997 |
| Operating Cash Flow | $-128,513 | $-345,102 | $-261,813 | $-180,334 | $-103,884 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,232 | -14,946 | -11,212 | -6,201 | -3,065 |
| Net Acquisitions | N/A | -78 | -78 | N/A | N/A |
| Purchase Of Investment | -153,792 | -954,646 | -848,754 | -673,111 | -339,169 |
| Sale Of Investment | 181,293 | 848,232 | 630,199 | 383,812 | 217,145 |
| Investing Cash Flow | $25,269 | $-121,438 | $-229,845 | $-295,500 | $-125,089 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 93,886 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 3,535 | 478,049 | 476,163 | 474,488 | 473,379 |
| Other Financing Activity | -813 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $96,608 | $478,049 | $476,163 | $474,488 | $473,379 |
| Beginning Cash Position | 301,620 | 290,111 | 290,111 | 290,111 | 290,111 |
| End Cash Position | 294,984 | 301,620 | 274,616 | 288,765 | 534,517 |
| Net Cash Flow | $-6,636 | $11,509 | $-15,495 | $-1,346 | $244,406 |
| Free Cash Flow | |||||
| Operating Cash Flow | -128,513 | -345,102 | -261,813 | -180,334 | -103,884 |
| Capital Expenditure | -2,232 | -14,946 | -11,212 | -6,201 | -3,065 |
| Free Cash Flow | -130,745 | -360,048 | -273,025 | -186,535 | -106,949 |